Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacement

Raniero Chimienti(Istituti di Ricovero e Cura a Carattere Scientifico), Lorenzo Piemonti(Vita-Salute San Raffaele University), Paolo Monti(IRCCS Ospedale San Raffaele), Valeria Sordi(Vita-Salute San Raffaele University), Angelo Lombardo(Vita-Salute San Raffaele University), Alessandro Cospito(IRCCS Ospedale San Raffaele), Mauro Malnati(Vita-Salute San Raffaele University), Silvia Pellegrini(Vita-Salute San Raffaele University), Fabio Manenti(IRCCS Ospedale San Raffaele), Angelo Amabile(Icahn School of Medicine at Mount Sinai), S. Torchio(Vita-Salute San Raffaele University), Marta Tiffany Lombardo(IRCCS Ospedale San Raffaele)
Cell Reports
September 1, 2022
10.1016/j.celrep.2022.111423
Cited by 33

Related Papers

Autoantibodies against type I IFNs in patients with life-threatening COVID-19
|Science|2020|2.9k
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets
|Blood|2005|606
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
|Immunity|1995|574
CD46 Is a Cellular Receptor for Human Herpesvirus 6
|Cell|1999|525